» Articles » PMID: 2035915

Effect of Oral Administration of Prednisolone on Thyroid Function in Dogs

Overview
Journal Am J Vet Res
Date 1991 Mar 1
PMID 2035915
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the effect of oral administration of prednisolone on thyroid function, 12 healthy Beagles were given 1.1 mg of prednisolone/kg of body weight every 12 hours for 22 days after 8 days of diagnostic testing of the dogs before treatment with prednisolone. Thyroid-stimulating hormone (TSH) and thyrotropin-releasing hormone (TRH) response tests were performed before treatment (days 1 and 8 of the study) and during treatment (days 21 and 28 of the study). Blood samples were collected daily at 8 AM and 2 and 8 PM to rule out normal daily hormone fluctuations as the cause of a potential decrease in serum triiodothyronine (T3), thyroxine (T4), and free T4 (fT4) concentrations. Serum T3, T4, and fT4 concentrations before treatment and 1 day and 21 days after the first prednisolone dose were compared by analyses of variance. Post-TSH and -TRH serum T3 and T4 concentrations before and during treatment were compared, using the Student t test for paired data. Oral administration of prednisolone significantly (P less than 0.005) decreased serum T3, T4, and fT4 concentrations in the 8 AM and 2 and 8 PM samples obtained 1 day and 21 days after the first prednisolone dose. Serum T4 and fT4 concentrations in 8 AM and 2 PM samples were significantly (P less than 0.05) lower 21 days after the first prednisolone dose than they were at 1 day after the first dose. Before treatment, serum T4 concentration in the 2 PM samples was significantly (P less than 0.05) higher than serum T4 concentration in 8 AM and 8 PM samples.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Assessment of the likelihood of hypothyroidism in dogs diagnosed with and treated for hypothyroidism at primary care practices: 102 cases (2016-2021).

Travail V, Fernandez Sanchez C, Costo J, Valentine N, Conroy M, Lee V J Vet Intern Med. 2024; 38(2):931-941.

PMID: 38314891 PMC: 10937491. DOI: 10.1111/jvim.16993.


Influence of medications on thyroid function in dogs: An update.

Bolton T, Panciera D J Vet Intern Med. 2023; 37(5):1626-1640.

PMID: 37498128 PMC: 10473007. DOI: 10.1111/jvim.16823.


Effects of Toceranib Phosphate on the Hypothalamic-Pituitary-Thyroid Axis in Tumor-Bearing Dogs.

Hume K, Rizzo V, Cawley J, Balkman C J Vet Intern Med. 2017; 32(1):377-383.

PMID: 29193327 PMC: 5787183. DOI: 10.1111/jvim.14882.


Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.

Khan M, Garg K, Bhurani D, Agarwal N Naunyn Schmiedebergs Arch Pharmacol. 2016; 389(12):1253-1265.

PMID: 27568029 DOI: 10.1007/s00210-016-1290-y.


Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases.

Long Y, Zheng Y, Chen M, Zhang B, Gao C, Shan F PLoS One. 2014; 9(8):e100672.

PMID: 25093326 PMC: 4122347. DOI: 10.1371/journal.pone.0100672.